Symbio Pharmaceuticals Reports Massive Exercise of Warrant Shares

TOKYO, Jul 30 (Pulse News Wire) – SymBio Pharmaceuticals Limited (4582.T) reported a significant exercise of warrant shares during the period from July 1, July 30, 2026 through July 29, 2026. During this period, 2,089,000 warrants were exercised out of a total issuance of 2,089,000 warrants, representing a 100% exercise rate.

As of June 30, there were 2,089,000 unexercised warrants outstanding, which decreased to 0 unexercised warrants by July 29, 2026. Key exercise details included: On July 7, 2026, 1,044,500 warrants were exercised, resulting in the delivery of 1,044,500 shares.

On July 29, another 1,044,500 warrants were exercised, delivering an additional 1,044,500 shares. Each warrant had an exercise price of ¥84 per share.

For more detailed information on the warrants, investors should refer to the July 22, 2025 press release titled “Issuance of Third-Party Allocation Warrants (Exercise Price Adjustment Clause Attached) and Conclusion of Unsecured Ordinary Bond Repurchase Agreement.”.